BiosimulantBiosimulant
Docs
Search labs...
Sign inGet Started

Lockwood2006 Alzheimer S Disease Pbpk Lab

About lab

Lockwood2006 - AlzheimersDisease PBPKmodel A mathematical model to predict theeffectiveness of CI-1017 (muscarinic agonist) for Alzheimer'sdisease by evaluating changes in ADAS-cog score. It can be used to explore systemsbiology lockwood2006 alzheimer s disease pbpk dynamics and compare simulation behavior across conditions.

Runtime

Duration1
Comms Step0.1

Runs

Total0
Completed0
Failed0

Metadata

Packagelockwood2006-alzheimer-s-disease-pbpk-lab
Created2026-05-17
Updated2026-05-17
neurosciencepharmacologysystemsbiologysbmlbiomodels_ebifaithfulcuratedvisualisation

Manifest

{
  "io": {
    "inputs": [],
    "outputs": [
      {
        "name": "state",
        "maps_to": "systemsbiology_sbml_lockwood2006_alzheimer_s_disease_pbpk_model_biomd0000000673_model.state"
      },
      {
        "name": "summary",
        "maps_to": "systemsbiology_sbml_lockwood2006_alzheimer_s_disease_pbpk_model_biomd0000000673_model.summary"
      },
      {
        "name": "species_labels",
        "maps_to": "systemsbiology_sbml_lockwood2006_alzheimer_s_disease_pbpk_model_biomd0000000673_model.species_labels"
      },
      {
        "name": "pd_ce_p",
        "maps_to": "systemsbiology_sbml_lockwood2006_alzheimer_s_disease_pbpk_model_biomd0000000673_model.pd_ce_p"
      },
      {
        "name": "pd_ce_a",
        "maps_to": "systemsbiology_sbml_lockwood2006_alzheimer_s_disease_pbpk_model_biomd0000000673_model.pd_ce_a"
      },
      {
        "name": "model_inactive",
        "maps_to": "systemsbiology_sbml_lockwood2006_alzheimer_s_disease_pbpk_model_biomd0000000673_model.model_inactive"
      },
      {
        "name": "model_active_u_shaped",
        "maps_to": "systemsbiology_sbml_lockwood2006_alzheimer_s_disease_pbpk_model_biomd0000000673_model.model_active_u_shaped"
      },
      {
        "name": "model_active_sigmoidal",
        "maps_to": "systemsbiology_sbml_lockwood2006_alzheimer_s_disease_pbpk_model_biomd0000000673_model.model_active_sigmoidal"
      },
      {
        "name": "model_active_linear",
        "maps_to": "systemsbiology_sbml_lockwood2006_alzheimer_s_disease_pbpk_model_biomd0000000673_model.model_active_linear"
      }
    ]
  },
  "tags": [
    "neuroscience",
    "pharmacology",
    "systemsbiology",
    "sbml",
    "biomodels_ebi",
    "faithful",
    "curated"
  ],
  "title": "Lockwood2006 Alzheimer S Disease Pbpk Lab",
  "models": [
    {
      "path": "owned/models/systemsbiology_sbml_lockwood2006_alzheimer_s_disease_pbpk_model_biomd0000000673_model",
      "alias": "systemsbiology_sbml_lockwood2006_alzheimer_s_disease_pbpk_model_biomd0000000673_model",
      "provenance": {
        "owned_path": "owned/models/systemsbiology_sbml_lockwood2006_alzheimer_s_disease_pbpk_model_biomd0000000673_model"
      }
    },
    {
      "path": "owned/models/visualisation",
      "alias": "visualisation",
      "provenance": {
        "owned_path": "owned/models/visualisation"
      }
    }
  ],
  "wiring": [
    {
      "to": [
        "visualisation.systemsbiology_sbml_lockwood2006_alzheimer_s_disease_pbpk_model_biomd0000000673_model_state"
      ],
      "from": "systemsbiology_sbml_lockwood2006_alzheimer_s_disease_pbpk_model_biomd0000000673_model.state"
    },
    {
      "to": [
        "visualisation.systemsbiology_sbml_lockwood2006_alzheimer_s_disease_pbpk_model_biomd0000000673_model_summary"
      ],
      "from": "systemsbiology_sbml_lockwood2006_alzheimer_s_disease_pbpk_model_biomd0000000673_model.summary"
    },
    {
      "to": [
        "visualisation.systemsbiology_sbml_lockwood2006_alzheimer_s_disease_pbpk_model_biomd0000000673_model_species_labels"
      ],
      "from": "systemsbiology_sbml_lockwood2006_alzheimer_s_disease_pbpk_model_biomd0000000673_model.species_labels"
    }
  ],
  "runtime": {
    "duration": 1,
    "initial_inputs": {},
    "communication_step": 0.1
  },
  "description": "Lockwood2006 - AlzheimersDisease PBPKmodel A mathematical model to predict theeffectiveness of CI-1017 (muscarinic agonist) for Alzheimer'sdisease by evaluating changes in ADAS-cog score. It can be used to explore systemsbiology lockwood2006 alzheimer s disease pbpk dynamics and compare simulation behavior across conditions.",
  "schema_version": "2.0"
}

Sign in to start your own run. Public-lab history stays visible here.

Select a run from History to view its results.